Colgate Announces 4th Quarter 2017 Results
Net income and Diluted earnings per share in fourth quarter 2017 were
Net income and Diluted earnings per share in fourth quarter 2016 were
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, the charge related to
Gross profit margin was 59.8% in fourth quarter 2017 versus 60.4% in fourth quarter 2016. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin was 60.4% in fourth quarter 2017, a decrease of 40 basis points versus the year ago quarter, as higher raw and packaging material costs and lower pricing were partially offset by cost savings from the Company's funding-the-growth initiatives.
Selling, general and administrative expenses were 35.3% of Net sales in
fourth quarter 2017 versus 33.7% of Net sales in fourth quarter 2016.
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, Selling, general and administrative expenses
increased 160 basis points to 34.5% of Net sales in fourth quarter 2017
as a result of increased advertising investment. Worldwide advertising
investment increased 24% to
Operating profit decreased to
Net cash provided by operations year to date decreased to
"Advertising investment increased both absolutely and as a percent to sales versus year ago across every operating division in the fourth quarter and for the year. We intend to increase our advertising investment in 2018 and to maintain the continuity of that investment throughout the year in support of new products, our base businesses and longer-term consumption-building activities.
"Colgate's leadership of the global toothpaste market continued during the quarter with our global market share now at 43.3% year to date. Our global leadership in manual toothbrushes also continued with Colgate's global market share in that category now at 32.6% year to date."
"On a GAAP basis, based on current spot rates and including the impact
of the Global Growth and Efficiency Program, we are planning for a year
of gross margin expansion and expect double-digit earnings per share
growth, including the impact of
"Excluding charges resulting from the Global Growth and Efficiency
Program and the one-time charge related to
At
The following are comments about divisional performance for fourth quarter 2017 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information tables for additional information on divisional net sales and operating profit.
North America Net sales increased 1.0% in fourth quarter 2017. Unit
volume increased 4.5% with 3.5% lower pricing, while foreign exchange
was even with the year ago quarter. Organic sales for
Operating profit in
In the
New products succeeding in other categories include
Latin America Net sales increased 4.0% in fourth quarter 2017. Unit
volume increased 4.0% with 1.5% lower pricing and foreign exchange was
positive 1.5%. Volume gains led by
Operating profit in
Colgate maintained its leadership in toothpaste in
New products contributing to growth in other categories include Colgate Total 12 and Colgate Plax Ice Glacial mouthwashes, Protex Pro-Hidrata shower gel and bar soap, Palmolive Natural Secrets shower gel and bar soap, Lady Speed Stick Derma + Aloe antiperspirant, Suavitel Sweet Pleasures fabric conditioner, Axion Fusion Clean dish liquid and Fabuloso Complete liquid cleaner.
Europe Net sales increased 13.0% in fourth quarter 2017. Unit volume
increased 6.0%, pricing decreased 2.0% and foreign exchange was positive
9.0%. Volume gains were led by
Operating profit in
Colgate maintained its oral care leadership in
Premium innovations succeeding in other categories include Sanex Zero% shower gels and deodorants, Palmolive Naturals with precious oils and Palmolive Gourmet shower gels, the Ajax Optimal 7 range of multi-benefit cleaners and Soupline Parfum Supreme line of fabric conditioners.
Asia Pacific Net sales increased 6.0% during fourth quarter 2017. Unit
volume increased 1.0% with 1.5% higher pricing and foreign exchange was
positive 3.5%. Volume gains in
Operating profit in
Colgate continued its toothpaste leadership in the
New products succeeding in other categories include Colgate Slim Soft Advanced, Colgate Slim Soft Micro Silky, Colgate Slim Soft Charcoal Spiral and Colgate Super Flexible manual toothbrushes, Protex Thai Therapy bar soap, Protex shower cream and Softlan Aroma Therapy fabric conditioner.
Operating profit in
Colgate continued its toothpaste leadership in
Hill's Pet Nutrition (15% of Company Sales)
Hill's Net sales increased 2.5% during fourth quarter 2017. Unit volume
was even with the year ago period, pricing increased 0.5% and foreign
exchange was positive 2.0%. Volume gains in
Hill's Operating profit decreased 1% in fourth quarter 2017 to
Successful products contributing to sales in the
Successful products contributing to sales internationally include Hill's Prescription Diet i/d, Hill's Prescription Diet k/d and k/d + Mobility, Hill's Prescription Diet Metabolic + Urinary, Hill's Prescription Diet Derm Defense, Hill's Science Diet Small & Mini and Hill's Science Diet Youthful Vitality.
***
About
The Company's annual meeting of stockholders is currently scheduled for
Market Share Information
Management uses market share information as a key indicator to monitor
business health and performance. References to market share in this
press release are based on a combination of consumption and market share
data provided by third-party vendors, primarily Nielsen, and internal
estimates. All market share references represent the percentage of the
dollar value of sales of our products, relative to all product sales in
the category in the countries in which the Company competes and
purchases data (excluding
The Company's provisional estimate of the one-time charge relating to
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements (as that term is defined in the
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
This release discusses Net sales growth (GAAP) and organic sales growth,
which is Net sales growth excluding the impact of foreign exchange,
acquisitions and divestments (non-GAAP). Management believes the organic
sales growth measure provides investors and analysts with useful
supplemental information regarding the Company's underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
"Geographic Sales Analysis Percentage Changes" for the three and twelve
months ended
To supplement Colgate's Condensed Consolidated Statements of Income
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is a non-GAAP measure
and may not be comparable to similarly titled measures reported by other
companies. See "Condensed Consolidated Statements of Cash Flows" for the
twelve months ended
(See attached tables for fourth quarter results.)
Table 1 | ||||||||||||||
|
||||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||||
For the Three Months Ended |
||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||
2017 | 2016 | |||||||||||||
Net sales | $ | 3,892 | $ | 3,721 | ||||||||||
Cost of sales | 1,564 | 1,474 | ||||||||||||
Gross profit | 2,328 | 2,247 | ||||||||||||
Gross profit margin | 59.8 | % | 60.4 | % | ||||||||||
Selling, general and administrative expenses | 1,373 | 1,253 | ||||||||||||
Other (income) expense, net | 31 | 39 | ||||||||||||
Operating profit (loss) | 924 | 955 | ||||||||||||
Operating profit margin | 23.7 | % | 25.7 | % | ||||||||||
Interest (income) expense, net | 28 | 21 | ||||||||||||
Income (loss) before income taxes | 896 | 934 | ||||||||||||
Provision for income taxes | 543 | 306 | ||||||||||||
Effective tax rate | 60.6 | % | 32.8 | % | ||||||||||
Net income (loss) including noncontrolling interests | 353 | 628 | ||||||||||||
Less: Net income attributable to noncontrolling interests | 30 | 22 | ||||||||||||
Net income (loss) attributable to |
$ | 323 | $ | 606 | ||||||||||
Earnings (loss) per common share | ||||||||||||||
Basic | $ | 0.37 | $ | 0.68 | ||||||||||
Diluted | $ | 0.37 | $ | 0.68 | ||||||||||
Average common shares outstanding | ||||||||||||||
Basic | 878.0 | 887.7 | ||||||||||||
Diluted | 883.3 | 893.2 | ||||||||||||
Table 2 | ||||||||||||||
|
||||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||||
For the Twelve Months Ended |
||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||
2017 | 2016 | |||||||||||||
Net sales | $ | 15,454 | $ | 15,195 | ||||||||||
Cost of sales | 6,174 | 6,072 | ||||||||||||
Gross profit | 9,280 | 9,123 | ||||||||||||
Gross profit margin | 60.0 | % | 60.0 | % | ||||||||||
Selling, general and administrative expenses | 5,497 | 5,249 | ||||||||||||
Other (income) expense, net | 194 | 37 | ||||||||||||
Operating profit | 3,589 | 3,837 | ||||||||||||
Operating profit margin | 23.2 | % | 25.3 | % | ||||||||||
Interest (income) expense, net | 102 | 99 | ||||||||||||
Income before income taxes | 3,487 | 3,738 | ||||||||||||
Provision for income taxes | 1,313 | 1,152 | ||||||||||||
Effective tax rate | 37.7 | % | 30.8 | % | ||||||||||
Net income including noncontrolling interests | 2,174 | 2,586 | ||||||||||||
Less: Net income attributable to noncontrolling interests | 150 | 145 | ||||||||||||
Net income attributable to |
$ | 2,024 | $ | 2,441 | ||||||||||
Earnings per common share | ||||||||||||||
Basic | $ | 2.30 | $ | 2.74 | ||||||||||
Diluted | $ | 2.28 | $ | 2.72 | ||||||||||
Average common shares outstanding | ||||||||||||||
Basic | 881.8 | 891.8 | ||||||||||||
Diluted | 887.8 | 898.4 | ||||||||||||
Table 3 | ||||||||
|
||||||||
Condensed Consolidated Balance Sheets | ||||||||
As of |
||||||||
(Dollars in Millions) (Unaudited) | ||||||||
|
|
|||||||
2017 | 2016 | |||||||
Cash and cash equivalents | $ | 1,535 | $ | 1,315 | ||||
Receivables, net | 1,480 | 1,411 | ||||||
Inventories | 1,221 | 1,171 | ||||||
Other current assets | 403 | 441 | ||||||
Property, plant and equipment, net | 4,072 | 3,840 | ||||||
Other assets, including goodwill and intangibles | 3,965 | 3,945 | ||||||
Total assets | $ | 12,676 | $ | 12,123 | ||||
Total debt | $ | 6,577 | $ | 6,533 | ||||
Other current liabilities | 3,397 | 3,292 | ||||||
Other non-current liabilities | 2,459 | 2,281 | ||||||
Total liabilities | 12,433 | 12,106 | ||||||
|
(60 | ) | (243 | ) | ||||
Noncontrolling interests | 303 | 260 | ||||||
Total liabilities and shareholders' equity | $ | 12,676 | $ | 12,123 | ||||
Supplemental Balance Sheet Information | ||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 5,024 | $ | 5,147 | ||||
Working capital % of sales | (2.0 | )% | (2.2 | )% | ||||
*Marketable securities of |
Table 4 | ||||||||||||||
|
||||||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||||||
For the Twelve Months Ended |
||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||
2017 | 2016 | |||||||||||||
Operating Activities | ||||||||||||||
Net income including noncontrolling interests | $ | 2,174 | $ | 2,586 | ||||||||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | ||||||||||||||
Depreciation and amortization | 475 | 443 | ||||||||||||
Restructuring and termination benefits, net of cash | 91 | (9 | ) | |||||||||||
Stock-based compensation expense | 127 | 123 | ||||||||||||
Gain on sale of land in |
— |
|
(97 | ) | ||||||||||
Charge for |
275 | — | ||||||||||||
Deferred income taxes | 108 | 56 | ||||||||||||
Voluntary benefit plan contributions |
(81 | ) | (53 | ) | ||||||||||
Cash effects of changes in: | ||||||||||||||
Receivables | (15 | ) | (17 | ) | ||||||||||
Inventories | (8 | ) | (4 | ) | ||||||||||
Accounts payable and other accruals | (96 | ) | 100 | |||||||||||
Other non-current assets and liabilities | 4 | 13 | ||||||||||||
Net cash provided by operations | 3,054 | 3,141 | ||||||||||||
Investing Activities | ||||||||||||||
Capital expenditures | (553 | ) | (593 | ) | ||||||||||
Sale of property and non-core products | 44 | — | ||||||||||||
Purchases of marketable securities and investments | (347 | ) | (336 | ) | ||||||||||
Proceeds from sale of marketable securities and investments | 391 | 378 | ||||||||||||
Proceeds from sale of land in |
— | 60 | ||||||||||||
Payment for acquisitions, net of cash acquired | — | (5 | ) | |||||||||||
Other | (6 | ) | (3 | ) | ||||||||||
Net cash used in investing activities | (471 | ) | (499 | ) | ||||||||||
Financing Activities | ||||||||||||||
Principal payments on debt | (4,808 | ) | (7,274 | ) | ||||||||||
Proceeds from issuance of debt | 4,779 | 7,438 | ||||||||||||
Dividends paid | (1,529 | ) | (1,508 | ) | ||||||||||
Purchases of treasury shares | (1,399 | ) | (1,335 | ) | ||||||||||
Proceeds from exercise of stock options | 507 | 446 | ||||||||||||
Net cash used in financing activities | (2,450 | ) | (2,233 | ) | ||||||||||
Effect of exchange rate changes on Cash and cash equivalents | 87 | (64 | ) | |||||||||||
Net increase (decrease) in Cash and cash equivalents | 220 | 345 | ||||||||||||
Cash and cash equivalents at beginning of the period | 1,315 | 970 | ||||||||||||
Cash and cash equivalents at end of the period | $ | 1,535 | $ | 1,315 | ||||||||||
Supplemental Cash Flow Information | ||||||||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | ||||||||||||||
Net cash provided by operations | $ | 3,054 | $ | 3,141 | ||||||||||
Less: Capital expenditures | (553 | ) | (593 | ) | ||||||||||
Free cash flow before dividends | $ | 2,501 | $ | 2,548 | ||||||||||
Income taxes paid | $ | 1,037 | $ | 932 | ||||||||||
Table 5 | ||||||||||||||||
|
||||||||||||||||
Segment Information | ||||||||||||||||
For the Three and Twelve Months Ended |
||||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||||
Three Months Ended |
Twelve Months Ended |
|||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
|
||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
|
$ | 798 | $ | 790 | $ | 3,117 | $ | 3,183 | ||||||||
|
976 | 940 | 3,887 | 3,650 | ||||||||||||
|
610 | 539 | 2,394 | 2,342 | ||||||||||||
|
670 | 633 | 2,781 | 2,796 | ||||||||||||
|
245 | 240 | 983 | 960 | ||||||||||||
Total Oral, Personal and Home Care | 3,299 | 3,142 | 13,162 | 12,931 | ||||||||||||
Pet Nutrition | 593 | 579 | 2,292 | 2,264 | ||||||||||||
Total |
$ | 3,892 | $ | 3,721 | $ | 15,454 | $ | 15,195 | ||||||||
Three Months Ended |
Twelve Months Ended |
|||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Operating Profit (Loss) | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
|
$ | 263 | $ | 268 | $ | 986 | $ | 1,030 | ||||||||
|
284 | 303 | 1,162 | 1,132 | ||||||||||||
|
152 | 142 | 599 | 579 | ||||||||||||
|
197 | 219 | 841 | 887 | ||||||||||||
|
45 | 48 | 179 | 186 | ||||||||||||
Total Oral, Personal and Home Care | 941 | 980 | 3,767 | 3,814 | ||||||||||||
Pet Nutrition | 172 | 174 | 653 | 653 | ||||||||||||
Corporate(1) | (189 | ) | (199 | ) | (831 | ) | (630 | ) | ||||||||
Total Operating Profit (Loss) | $ | 924 | $ | 955 | $ | 3,589 | $ | 3,837 | ||||||||
Note: |
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. |
Corporate Operating profit (loss) for the three months ended
|
Corporate Operating profit (loss) for the twelve months ended
|
Table 6 | ||||||||||||||
|
||||||||||||||
Geographic Sales Analysis Percentage Changes | ||||||||||||||
For the Three Months Ended |
||||||||||||||
(Unaudited) | ||||||||||||||
COMPONENTS OF SALES CHANGE | ||||||||||||||
Pricing | ||||||||||||||
Coupons | ||||||||||||||
Sales | Consumer & | |||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | ||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
|||||||
|
4.5% | 2.0% | 3.0% | 3.0% | 3.0% | (1.0)% | 2.5% | |||||||
|
13.0% | 4.0% | 6.0% | 6.0% | 6.0% | (2.0)% | 9.0% | |||||||
|
4.0% | 2.5% | 4.0% | 4.0% | 4.0% | (1.5)% | 1.5% | |||||||
|
6.0% | 2.5% | 1.0% | 1.0% | 1.0% | 1.5% | 3.5% | |||||||
|
2.0% | (0.5)% | (0.5)% | (0.5)% | (0.5)% | —% | 2.5% | |||||||
|
6.5% | 2.5% | 3.0% | 3.0% | 3.0% | (0.5)% | 4.0% | |||||||
|
1.0% | 1.0% | 4.5% | 4.5% | 4.5% | (3.5)% | —% | |||||||
Total CP Products | 5.0% | 2.0% | 3.5% | 3.5% | 3.5% | (1.5)% | 3.0% | |||||||
Hill's | 2.5% | 0.5% | —% | —% | —% | 0.5% | 2.0% | |||||||
Emerging Markets (1) | 5.0% | 2.5% | 2.5% | 2.5% | 2.5% | —% | 2.5% | |||||||
Developed Markets | 4.5% | 1.5% | 3.5% | 3.5% | 3.5% | (2.0)% | 3.0% | |||||||
Notes: |
(1) Emerging Markets include |
Table 7 | ||||||||||||||
|
||||||||||||||
Geographic Sales Analysis Percentage Changes | ||||||||||||||
For the Twelve Months Ended |
||||||||||||||
(Unaudited) | ||||||||||||||
COMPONENTS OF SALES CHANGE | ||||||||||||||
Pricing | ||||||||||||||
Coupons | ||||||||||||||
Sales | Consumer & | |||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | ||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
|||||||
|
1.5% | 1.0% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | |||||||
|
2.0% | 1.0% | 2.0% | 2.0% | 2.0% | (1.0)% | 1.0% | |||||||
|
6.5% | 5.5% | 2.5% | 2.5% | 2.5% | 3.0% | 1.0% | |||||||
|
(0.5)% | (0.5)% | (0.5)% | (0.5)% | (0.5)% | —% | —% | |||||||
|
2.5% | (1.0)% | (4.5)% | (4.5)% | (4.5)% | 3.5% | 3.5% | |||||||
|
3.0% | 2.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | |||||||
|
(2.0)% | (2.0)% | —% | —% | —% | (2.0)% | —% | |||||||
Total CP Products | 2.0% | 1.0% | 0.5% | 0.5% | 0.5% | 0.5% | 1.0% | |||||||
Hill's | 1.0% | 0.5% | (1.0)% | (1.0)% | (1.0)% | 1.5% | 0.5% | |||||||
Emerging Markets (1) | 4.0% | 3.0% | 0.5% | 0.5% | 0.5% | 2.5% | 1.0% | |||||||
Developed Markets | (0.5)% | (1.0)% | —% | —% | —% | (1.0)% |
0.5% |
|||||||
Notes: |
(1) Emerging Markets include |
Table 8 | ||||||||||||||||||||||
|
||||||||||||||||||||||
Non-GAAP Reconciliations | ||||||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||||||||||
Gross Profit | 2017 | 2016 | ||||||||||||||||||||
Gross profit, GAAP | $ | 2,328 | $ | 2,247 | ||||||||||||||||||
Global Growth and Efficiency Program | 24 | 15 | ||||||||||||||||||||
Gross profit, non-GAAP | $ | 2,352 | $ | 2,262 | ||||||||||||||||||
|
||||||||||||||||||||||
Gross Profit Margin | 2017 | 2016 | Change | |||||||||||||||||||
Gross profit margin, GAAP | 59.8 | % | 60.4 | % | (60 | ) | ||||||||||||||||
Global Growth and Efficiency Program | 0.6 | % | 0.4 | % | ||||||||||||||||||
Gross profit margin, non-GAAP | 60.4 | % | 60.8 | % | (40 | ) | ||||||||||||||||
Selling, General and Administrative Expenses | 2017 | 2016 | ||||||||||||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,373 | $ | 1,253 | ||||||||||||||||||
Global Growth and Efficiency Program | (29 | ) | (28 | ) | ||||||||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,344 | $ | 1,225 | ||||||||||||||||||
|
||||||||||||||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2017 | 2016 | Change | |||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.3 | % | 33.7 | % | 160 | |||||||||||||||||
Global Growth and Efficiency Program | (0.8 | )% | (0.8 | )% | ||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 34.5 | % | 32.9 | % | 160 | |||||||||||||||||
Other (Income) Expense, Net | 2017 | 2016 | ||||||||||||||||||||
Other (income) expense, net, GAAP | $ | 31 | $ | 39 | ||||||||||||||||||
Global Growth and Efficiency Program | (34 | ) | (29 | ) | ||||||||||||||||||
Charge for a litigation matter | — | (11 | ) | |||||||||||||||||||
Other (income) expense, net, non-GAAP | $ | (3 | ) | $ | (1 | ) | ||||||||||||||||
Operating Profit (Loss) | 2017 | 2016 | % Change | |||||||||||||||||||
Operating profit (loss), GAAP | $ | 924 | $ | 955 | (3 | )% | ||||||||||||||||
Global Growth and Efficiency Program | 87 | 72 | ||||||||||||||||||||
Charge for a litigation matter | — | 11 | ||||||||||||||||||||
Operating profit, non-GAAP | $ | 1,011 | $ | 1,038 | (3 | )% | ||||||||||||||||
|
||||||||||||||||||||||
Operating Profit Margin | 2017 | 2016 | Change | |||||||||||||||||||
Operating profit margin, GAAP | 23.7 | % | 25.7 | % | (200 | ) | ||||||||||||||||
Global Growth and Efficiency Program | 2.3 | % | 1.9 | % | ||||||||||||||||||
Charge for a litigation matter | — | % | 0.3 | % | ||||||||||||||||||
Operating profit margin, non-GAAP | 26.0 | % | 27.9 | % | (190 | ) | ||||||||||||||||
Table 8 | ||||||||||||||||||||||
Continued | ||||||||||||||||||||||
|
||||||||||||||||||||||
Non-GAAP Reconciliations | ||||||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||||||||||
2017 | ||||||||||||||||||||||
Income Before |
Provision For |
Net Income |
Net Income |
Effective |
Diluted |
|||||||||||||||||
As Reported GAAP | $ | 896 | $ | 543 | $ | 353 | $ | 323 | 60.6 | % | $ | 0.37 | ||||||||||
Global Growth and Efficiency Program | 87 | 26 | 61 | 61 | (2.7 | )% | 0.07 | |||||||||||||||
|
— | (275 | ) | 275 | 275 | (28.0 | )% | 0.31 | ||||||||||||||
Non-GAAP | $ | 983 | $ | 294 | $ | 689 | $ | 659 | 29.9 | % | $ | 0.75 | ||||||||||
2016 | ||||||||||||||||||||||
Income Before |
Provision For |
Net Income |
Net Income |
Effective |
Diluted |
|||||||||||||||||
As Reported GAAP | $ | 934 | $ | 306 | $ | 628 | $ | 606 | 32.8 | % | $ | 0.68 | ||||||||||
Global Growth and Efficiency Program | 72 | 18 | 54 | 54 | (0.5 | )% | 0.06 | |||||||||||||||
Charge for a litigation matter | 11 | 4 | 7 | 7 | — | % | 0.01 | |||||||||||||||
Non-GAAP | $ | 1,017 | $ | 328 | $ | 689 | $ | 667 | 32.3 | % | $ | 0.75 | ||||||||||
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding. |
Table 9 | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||
For the Twelve Months Ended |
|||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||
Gross Profit | 2017 | 2016 | |||||||||||||||||||||
Gross profit, GAAP | $ | 9,280 | $ | 9,123 | |||||||||||||||||||
Global Growth and Efficiency Program | 75 | 46 | |||||||||||||||||||||
Gross profit, non-GAAP | $ | 9,355 | $ | 9,169 | |||||||||||||||||||
|
|||||||||||||||||||||||
Gross Profit Margin | 2017 | 2016 | Change | ||||||||||||||||||||
Gross profit margin, GAAP | 60.0 | % | 60.0 | % | — | ||||||||||||||||||
Global Growth and Efficiency Program | 0.5 | % | 0.3 | % | |||||||||||||||||||
Gross profit margin, non-GAAP | 60.5 | % | 60.3 | % | 20 | ||||||||||||||||||
Selling, General and Administrative Expenses | 2017 | 2016 | |||||||||||||||||||||
Selling, general and administrative expenses, GAAP | $ | 5,497 | $ | 5,249 | |||||||||||||||||||
Global Growth and Efficiency Program | (89 | ) | (77 | ) | |||||||||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 5,408 | $ | 5,172 | |||||||||||||||||||
|
|||||||||||||||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2017 | 2016 | Change | ||||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.6 | % | 34.5 | % | 110 | ||||||||||||||||||
Global Growth and Efficiency Program | (0.6 | )% | (0.5 | )% | |||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.0 | % | 34.0 | % | 100 | ||||||||||||||||||
Other (Income) Expense, Net | 2017 | 2016 | |||||||||||||||||||||
Other (income) expense, net, GAAP | $ | 194 | $ | 37 | |||||||||||||||||||
Global Growth and Efficiency Program | (169 | ) | (105 | ) | |||||||||||||||||||
Gain on sale of land in |
— | 97 | |||||||||||||||||||||
Charge for a litigation matter | — | (17 | ) | ||||||||||||||||||||
Other (income) expense, net, non-GAAP | $ | 25 | $ | 12 | |||||||||||||||||||
Operating Profit | 2017 | 2016 | % Change | ||||||||||||||||||||
Operating profit, GAAP | $ | 3,589 | $ | 3,837 | (6 | )% | |||||||||||||||||
Global Growth and Efficiency Program | 333 | 228 | |||||||||||||||||||||
Gain on sale of land in |
— | (97 | ) | ||||||||||||||||||||
Charge for a litigation matter | — | 17 | |||||||||||||||||||||
Operating profit, non-GAAP | $ | 3,922 | $ | 3,985 | (2 | )% | |||||||||||||||||
|
|||||||||||||||||||||||
Operating Profit Margin | 2017 | 2016 | Change | ||||||||||||||||||||
Operating profit margin, GAAP | 23.2 | % | 25.3 | % | (210 | ) | |||||||||||||||||
Global Growth and Efficiency Program | 2.2 | % | 1.5 | % | |||||||||||||||||||
Gain on sale of land in |
— | % | (0.7 | )% | |||||||||||||||||||
Charge for a litigation matter | — | % | 0.1 | % | |||||||||||||||||||
Operating profit margin, non-GAAP | 25.4 | % | 26.2 | % | (80 | ) | |||||||||||||||||
Table 9 | |||||||||||||||||||||||||||
Continued | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||||||
For the Twelve Months Ended |
|||||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||||
Income Before |
Provision |
Net Income |
Net Income |
Effective |
Diluted |
||||||||||||||||||||||
As Reported GAAP | $ | 3,487 | $ | 1,313 | $ | 2,174 | $ | 2,024 | 37.7 | % | $ | 2.28 | |||||||||||||||
Global Growth and Efficiency Program | 333 | 87 | 246 | 246 | (1.0 | )% | 0.28 | ||||||||||||||||||||
|
— | (275 | ) | 275 | 275 | (7.2 | )% | 0.31 | |||||||||||||||||||
Non-GAAP | $ | 3,820 | $ | 1,125 | $ | 2,695 | $ | 2,545 | 29.5 | % | $ | 2.87 | |||||||||||||||
2016 | |||||||||||||||||||||||||||
Income |
Provision |
Net Income |
Less: |
Net Income |
Effective |
Diluted |
|||||||||||||||||||||
As Reported GAAP | $ | 3,738 | $ | 1,152 | $ | 2,586 | $ | 145 | $ | 2,441 | 30.8 | % | $ | 2.72 | |||||||||||||
Global Growth and Efficiency Program | 228 | 59 | 169 | 1 | 168 | (0.3 | )% | 0.19 | |||||||||||||||||||
Gain on sale of land in |
(97 | ) | (34 | ) | (63 | ) | — | (63 | ) | (0.1 | )% | (0.07 | ) | ||||||||||||||
Benefits from tax matters | — | 35 | (35 | ) | — | (35 | ) | 0.9 | % | (0.04 | ) | ||||||||||||||||
Charge for a litigation matter | 17 | 6 | 11 | — | 11 | — | % | 0.01 | |||||||||||||||||||
Non-GAAP | $ | 3,886 | $ | 1,218 | $ | 2,668 | $ | 146 | $ | 2,522 | 31.3 | % | $ | 2.81 | |||||||||||||
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding. |
View source version on businesswire.com: http://www.businesswire.com/news/home/20180126005067/en/
Source:
News Provided by Acquire Media